Raphael Pharmaceutical (RAPH) Prepaid Assets (2020 - 2026)
Raphael Pharmaceutical's (RAPH) quarterly Prepaid Assets came in at $5000.0 in Q2 2026, down 37.5% year-over-year from $8000.0 in Q2 2025, and down 16.67% quarter-over-quarter from $6000.0 in Q4 2025.
Analysis
Raphael Pharmaceutical (RAPH) Prepaid Assets (2020 - 2026) Analysis & Trends
Raphael Pharmaceutical has disclosed Prepaid Assets across 7 years of filings, most recently posting $5000.0 for Q2 2026.
- In Q2 2026, Prepaid Assets fell 37.5% year-over-year to $5000.0; the TTM figure through Jun 2026 stood at $5000.0 (down 37.5% YoY), while the FY2025 annual figure was $6000.0, changed 0.0% from the prior year.
- Prepaid Assets came in at $5000.0 for Q2 2026 at Raphael Pharmaceutical, down from $6000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $111000.0 in Q1 2023 to a low of $2000.0 in Q3 2025.
- Average Prepaid Assets over 5 years is $35470.6, with a median of $9000.0 recorded in 2024.
- Year-over-year, Prepaid Assets soared 296.15% in 2023 and sank 91.26% in 2024.
- Over 5 years, Prepaid Assets stood at $43000.0 in 2022, then slumped by 83.72% to $7000.0 in 2023, then fell by 14.29% to $6000.0 in 2024, then changed by 0.0% to $6000.0 in 2025, then dropped by 16.67% to $5000.0 in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $5000.0 in Q2 2026, $6000.0 in Q4 2025, and $2000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 103,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 111,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Jun 30, 2022 | 61,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | 269,000.00 |
| Sep 30, 2021 | 25,000.00 |
| Dec 31, 2020 | 228,000.00 |